Back to results
US 11,566,007 B2Granted
Ras inhibitors
AssigneeRevolution Medicines, Inc.
InventorsElena S. Koltun, James Cregg, Adrian L. Gill, Andreas Buckl, Yang Liu
Life of this patent
Estimating the term…
Abstract
The disclosure features macrocyclic compounds, and pharmaceutical compositions and protein complexes thereof, capable of inhibiting Ras proteins, and their uses in the treatment of cancers.
Claims2
A compound, or a pharmaceutically acceptable salt thereof, selected from the following compounds:
- Ex #
- Structure
- A202
- A248
- A276
- A277
- A278
- A279
- A286
- A287
- A288
- A314
- A330
- A331
- A340
- A347
- A447
- A468
- A506
- A520
- A521
- A694
- A728
- .
21 more elements
Dependencies are inferred from the claim text.